Athletic-Therapeutic-Pharma (ATP)
FDA import alert and refusal historyGranby, CanadaFEI 3014114273
As of October 26, 2026, Athletic-Therapeutic-Pharma (ATP) is not on any FDA import alert in SupplierRadar's records; FDA refused 2 of its shipment lines between September 21, 2018 and March 5, 2020, most often for not identified as a dietary supplement (DIETARYLBL).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Foods with supplemental nutrients added, with or without artifical sweetners · DIETARYLBL
- Last warning letter
- None found
- Last inspection
- Classified VAI (Voluntary Action Indicated)
Every FDA record for Athletic-Therapeutic-Pharma (ATP)
3 records, newest first. Each line links to the FDA page it came from.
2025
- InspectionInspection classified VAI (Voluntary Action Indicated)Food Composition, Standards, Labeling and Econ; Foodborne Biological HazardsSource
2020
- Import refusalRefused, Foods with supplemental nutrients added, with or without artifical sweetnersDIETARYLBLNCONTACTNUTRIT LBLHEALTH CUNAPPROVEDEntry AEK-6892582-2Source
2018
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLNCONTACTLABELINGHEALTH CEntry AEK-5143478-2Source
Refusal charges, in plain English
- DIETARYLBL2 refused lines
Not identified as a dietary supplement
The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).
- HEALTH C2 refused lines
Unauthorized nutrient content or health claim
The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.
- NCONTACT2 refused lines
No U.S. adverse event contact on supplement label
The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.
- LABELING1 refused line
Fair Packaging and Labeling Act
The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.
- NUTRIT LBL1 refused line
Nutrition information missing from label
The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.
- UNAPPROVED1 refused line
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
Questions about Athletic-Therapeutic-Pharma (ATP)
- Is Athletic-Therapeutic-Pharma (ATP) on an FDA import alert?
- No listing for Athletic-Therapeutic-Pharma (ATP) appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Canada page.
- Has FDA refused shipments from Athletic-Therapeutic-Pharma (ATP)?
- Yes. FDA refused 2 shipment lines from Athletic-Therapeutic-Pharma (ATP) between September 21, 2018 and March 5, 2020. The most recent, on March 5, 2020, was foods with supplemental nutrients added, with or without artifical sweetners, charged as DIETARYLBL (not identified as a dietary supplement).
- Why did FDA refuse Athletic-Therapeutic-Pharma (ATP)'s shipments?
- The most frequent charges are DIETARYLBL (not identified as a dietary supplement, 2 lines) and HEALTH C (unauthorized nutrient content or health claim, 2 lines).
- When was Athletic-Therapeutic-Pharma (ATP) last inspected by FDA?
- FDA's most recent inspection of Athletic-Therapeutic-Pharma (ATP) with a final classification is dated February 28, 2025 and was classified VAI (Voluntary Action Indicated).
- What is Athletic-Therapeutic-Pharma (ATP)'s FEI number?
- Athletic-Therapeutic-Pharma (ATP)'s FDA Establishment Identifier (FEI) is 3014114273.
Buying from Athletic-Therapeutic-Pharma (ATP)?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.